Stock MPL MEDIBANK PRIVATE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medibank Private Limited

Equities

MPL

AU000000MPL3

Life & Health Insurance

Market Closed - Australian S.E.
Other stock markets
 02:10:43 2024-04-26 am EDT 		5-day change 1st Jan Change
3.56 AUD -1.93% Intraday chart for Medibank Private Limited -0.84% 0.00%
Mar. 06 Morgan Stanley Adjusts Medibank Private’s Price Target to AU$3.84 From AU$3.66, Keeps at Equalweight MT
Feb. 23 Jarden Research Downgrades Medibank Private to Neutral From Overweight, Keeps Price Target at AU$3.75 MT

Valuation

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,611 8,234 8,703 8,951 9,694 9,804 - -
Enterprise Value (EV) 1 6,824 5,368 5,719 5,499 6,407 6,718 6,552 6,378
P/E ratio 20.9 x 26.2 x 19.8 x 22.7 x 18.9 x 17 x 17.2 x 16.3 x
Yield 3.75% 4.01% 4.02% 4.12% 4.15% 4.46% 4.74% 4.96%
Capitalization / Revenue 1.35 x 1.22 x 1.26 x 1.26 x 1.32 x 1.21 x 1.17 x 1.12 x
EV / Revenue 0.96 x 0.79 x 0.83 x 0.77 x 0.87 x 0.83 x 0.78 x 0.73 x
EV / EBITDA 10.3 x 9.13 x 9.36 x 7.76 x 8.36 x 10.1 x 9.35 x 9.09 x
EV / FCF - - - -5.58 x -4.2 x 17.7 x 11 x 10.8 x
FCF Yield - - - -17.9% -23.8% 5.67% 9.1% 9.28%
Price to Book 4.97 x 4.54 x 4.57 x 4.6 x 4.65 x 4.41 x 4.26 x 4.08 x
Nbr of stocks (in thousands) 2,754,003 2,754,003 2,754,003 2,754,003 2,754,003 2,754,003 - -
Reference price 2 3.490 2.990 3.160 3.250 3.520 3.560 3.560 3.560
Announcement Date 8/21/19 8/19/20 8/24/21 8/17/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,110 6,770 6,910 7,128 7,355 8,108 8,410 8,764
EBITDA 1 662.8 587.9 611 709.1 765.9 668.2 700.6 701.8
EBIT 1 528.5 461 528.3 594.1 647.5 723.3 740.4 766.7
Operating Margin 7.43% 6.81% 7.64% 8.33% 8.8% 8.92% 8.8% 8.75%
Earnings before Tax (EBT) 1 616.3 450.2 632.3 560 727.1 806.5 837.4 865
Net income 1 458.7 315 441.2 393.9 511.1 581.1 581.5 601.7
Net margin 6.45% 4.65% 6.38% 5.53% 6.95% 7.17% 6.91% 6.87%
EPS 2 0.1670 0.1140 0.1600 0.1430 0.1860 0.2100 0.2065 0.2184
Free Cash Flow 1 - - - -984.7 -1,527 380.6 596 592
FCF margin - - - -13.81% -20.76% 4.69% 7.09% 6.75%
FCF Conversion (EBITDA) - - - - - 56.96% 85.07% 84.35%
FCF Conversion (Net income) - - - - - 65.5% 102.49% 98.38%
Dividend per Share 2 0.1310 0.1200 0.1270 0.1340 0.1460 0.1587 0.1689 0.1765
Announcement Date 8/21/19 8/19/20 8/24/21 8/17/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Juni 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 3,422 3,348 3,442 3,468 3,581 3,547 3,629 3,726 4,024 4,090 4,211 4,272
EBITDA - - - - - - - - - - - -
EBIT 1 218.8 - - 273.1 286.5 307.6 307.8 339.7 319.4 364 - -
Operating Margin 6.39% - - 7.87% 8% 8.67% 8.48% 9.12% 7.94% 8.9% - -
Earnings before Tax (EBT) 1 - - - - 313.2 246.8 332.1 395 491.9 420 - -
Net income 1 - - - 214.8 220.2 173.7 233.3 277.8 343.2 294 - -
Net margin - - - 6.19% 6.15% 4.9% 6.43% 7.46% 8.53% 7.19% - -
EPS 2 - 0.0500 0.0820 0.0780 0.0800 0.0630 0.0850 0.1010 0.1250 0.0785 0.1000 0.1200
Dividend per Share 2 0.0570 - - 0.0690 0.0610 0.0730 0.0630 0.0830 0.0720 0.0910 - -
Announcement Date 2/19/20 8/19/20 2/23/21 8/24/21 2/24/22 8/17/22 2/22/23 8/23/23 2/21/24 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,787 2,866 2,984 3,451 3,287 3,086 3,253 3,426
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - -985 -1,527 381 596 592
ROE (net income / shareholders' equity) 23.8% 16.8% 23.8% 20.5% 25.4% 24.9% 25.1% 24.7%
ROA (Net income/ Total Assets) 12.5% 8.52% 11.5% 9.29% 11.4% 13.5% 14.1% 14%
Assets 1 3,674 3,697 3,836 4,238 4,471 4,310 4,139 4,289
Book Value Per Share 2 0.7000 0.6600 0.6900 0.7100 0.7600 0.8100 0.8400 0.8700
Cash Flow per Share 2 - - 0.2700 0.3400 - 0.1400 0.2200 0.2100
Capex 1 49.5 29.3 35.1 7 1,711 920 30.5 31.5
Capex / Sales 0.7% 0.43% 0.51% 0.1% 23.27% 11.35% 0.36% 0.36%
Announcement Date 8/21/19 8/19/20 8/24/21 8/17/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Medibank Private Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
3.56 AUD
Average target price
3.872 AUD
Spread / Average Target
+8.75%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Health Insurance

1st Jan change Capi.
MEDIBANK PRIVATE LIMITED Stock Medibank Private Limited
0.00% 6.39B
BUPA ARABIA FOR COOPERATIVE INSURANCE COMPANY Stock Bupa Arabia for Cooperative Insurance Company
+13.21% 9.63B
THE COMPANY FOR COOPERATIVE INSURANCE Stock The Company for Cooperative Insurance
+16.74% 6.08B
OSCAR HEALTH, INC. Stock Oscar Health, Inc.
+91.91% 4.16B
NIB HOLDINGS LIMITED Stock nib holdings limited
-1.08% 2.31B
TRUPANION, INC. Stock Trupanion, Inc.
-20.94% 1.01B
RELIGARE ENTERPRISES LIMITED Stock Religare Enterprises Limited
+2.18% 862M
THE MEDITERRANEAN AND GULF COOPERATIVE INSURANCE AND REINSURANCE COMPANY Stock The Mediterranean and Gulf Cooperative Insurance and Reinsurance Company
+85.42% 748M
PT LIPPO GENERAL INSURANCE TBK Stock PT Lippo General Insurance Tbk
-8.15% 68.79M
Health Insurance
  1. Stock Market
  2. Equities
  3. MPL Stock
  4. Financials Medibank Private Limited